These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38173145)

  • 1. Combining QSAR techniques, molecular docking, and molecular dynamics simulations to explore anti-tumor inhibitors targeting Focal Adhesion Kinase.
    Liu Y; Tong JB; Gao P; Fan XL; Xiao XC; Xing YC
    J Biomol Struct Dyn; 2024 Jan; ():1-17. PubMed ID: 38173145
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Shirvani P; Fassihi A
    J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR analysis of 3-pyrimidin-4-yl-oxazolidin-2-one derivatives isocitrate dehydrogenase inhibitors using Topomer CoMFA and HQSAR methods.
    Tong JB; Bian S; Zhang X; Luo D
    Mol Divers; 2022 Apr; 26(2):1017-1037. PubMed ID: 33974175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer.
    Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG
    Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of novel anti-cancer drugs targeting TRKs inhibitors based 3D QSAR, molecular docking and molecular dynamics simulation.
    Er-Rajy M; El Fadili M; Mujwar S; Zarougui S; Elhallaoui M
    J Biomol Struct Dyn; 2023; 41(21):11657-11670. PubMed ID: 36695085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the binding mechanism of substituted pyridine derivatives as effective and selective lysine-specific demethylase 1 inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations.
    Wang ZZ; Yang J; Sun XD; Ma CY; Gao QB; Ding L; Liu HM
    J Biomol Struct Dyn; 2019 Aug; 37(13):3482-3495. PubMed ID: 30175693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of novel dopamine D
    Zhang C; Li Q; Meng L; Ren Y
    J Biomol Struct Dyn; 2020 Feb; 38(3):860-885. PubMed ID: 30916624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential FAK inhibitors using mol2vec molecular descriptor-based QSAR, molecular docking, ADMET study, and molecular dynamics simulation.
    Hang NT; My TTK; Van Anh LT; Van Anh PT; Anh TDH; Van Phuong N
    Mol Divers; 2024 Aug; 28(4):2163-2175. PubMed ID: 38582821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling studies of pyrrolo[2,3-d]pyrimidin-4-amine derivatives as JAK1 inhibitors based on 3D-QSAR, molecular docking, molecular dynamics (MD) and MM-PBSA calculations.
    Keretsu S; Bhujbal SP; Cho SJ
    J Biomol Struct Dyn; 2021 Feb; 39(3):753-765. PubMed ID: 31916502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations of FAK inhibitors: a combination of 3D-QSAR, docking, and molecular dynamics simulations studies.
    Cheng P; Li J; Wang J; Zhang X; Zhai H
    J Biomol Struct Dyn; 2018 May; 36(6):1529-1549. PubMed ID: 28490269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined HQSAR, topomer CoMFA, homology modeling and docking studies on triazole derivatives as SGLT2 inhibitors.
    Yu S; Yuan J; Zhang Y; Gao S; Gan Y; Han M; Chen Y; Zhou Q; Shi J
    Future Med Chem; 2017 Jun; 9(9):847-858. PubMed ID: 28635308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
    El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
    J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of defactinib derivatives targeting focal adhesion kinase using ensemble docking, molecular dynamics simulations and binding free energy calculations.
    Guo C; Li Q; Xiao J; Ma F; Xia X; Shi M
    J Biomol Struct Dyn; 2023; 41(18):8654-8670. PubMed ID: 36281703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    Med Chem; 2020; 16(7):903-927. PubMed ID: 31385775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel bromodomain-containing protein 4 (BRD4-BD1) inhibitors combined with 3d-QSAR, molecular docking and molecular dynamics in silico.
    Liu R; Chen X; Li J; Liu X; Shu M
    J Biomol Struct Dyn; 2024 Feb; ():1-18. PubMed ID: 38425011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
    Gajjar KA; Gajjar AK
    Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Widely-targeted in silico and in vitro evaluation of veratrum alkaloid analogs as FAK inhibitors and dual targeting of FAK and Hh/SMO pathways for cancer therapy: A critical analysis.
    Mosoh DA
    Int J Biol Macromol; 2024 Nov; 281(Pt 2):136201. PubMed ID: 39368576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural modification of 4, 5-dihydro-[1, 2, 4] triazolo [4, 3-f] pteridine derivatives as BRD4 inhibitors using 2D/3D-QSAR and molecular docking analysis.
    Tong JB; Luo D; Feng Y; Bian S; Zhang X; Wang TH
    Mol Divers; 2021 Aug; 25(3):1855-1872. PubMed ID: 33392965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quionolone carboxylic acid derivatives as HIV-1 integrase inhibitors: Docking-based HQSAR and topomer CoMFA analyses.
    Tong J; Zhan P; Wang XS; Wu Y
    J Chemom; 2017 Dec; 31(12):. PubMed ID: 29606793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D-QSAR, molecular docking, and molecular dynamics simulation of a novel thieno[3,4-d]pyrimidine inhibitor targeting human immunodeficiency virus type 1 reverse transcriptase.
    Chu H; He QX; Wang JW; Deng YT; Wang J; Hu Y; Wang YQ; Lin ZH
    J Biomol Struct Dyn; 2020 Sep; 38(15):4567-4578. PubMed ID: 31760877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.